Jim Cramer Likes Eli Lilly's (LLY) New Deal [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Pharma giant Eli Lilly and Company (NYSE:LLY) is one of Jim Cramer's favorite stocks in the sector. Its shares are up by 18.6% over the past year and down by 13.4% year-to-date. However, over the past five days, Eli Lilly and Company (NYSE:LLY)'s stock is up by 4.6%. It closed 7.6% higher between March 30th and April 1st. On March 31st, the firm announced that it would acquire sleep disorder treatment maker Centessa for a $7.8 billion price tag. Estimates from analysts suggested that Centessa's drugs could represent a market that is as large as $20 billion. On April 1st, the Food and Drug Administration (FDA) approved Eli Lilly and Company (NYSE:LLY)'s GLP-1 weight loss pill called Foundayo. Cramer commented on the acquisition: “You know, one of the things that your eyes glaze over in these deals, that are under ten billion. They bought Centessa for 7.8 billion and I just said, oh it was just a sleep disorder thing. No, it's a peptide, that impacts brain for many, many different wa
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- 25th Annual Bio-IT World Conference & Expo in Boston Leads the Conversation on Operationalizing AI Across Real-World Drug Discovery Environments [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (LLY) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=LLY&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "stMarketBeat
- Eli Lilly Obesity Pill Approval And Sleep Deal Reshape Growth Story [Yahoo! Finance]Yahoo! Finance
- Jim Cramer Believes Eli Lilly's “Weight Loss Pill Will Be a Blockbuster” [Yahoo! Finance]Yahoo! Finance
- Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form DEFA14A
- 3/20/26 - Form DEF
- LLY's page on the SEC website